Mainehealth
Mainehealth was paid $6.54M by Medicaid between Jan 2018 and Dec 2023, across 101 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 48% of everything it billed.
FALMOUTH, ME 04105
Next to other General Acute Care Hospital providers in Maine
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,355 | $1.17M | |
| 2019 | 33,508 | $1.06M | |
| 2020 | 28,620 | $831K | |
| 2021 | 30,921 | $983K | |
| 2022 | 32,865 | $1.22M | |
| 2023 | 30,412 | $1.27M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 48% | 32,822 | 29,246 | $3.12M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.4% | 8,993 | 8,952 | $548K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 7.2% | 15,285 | 15,061 | $469K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.1% | 7,576 | 7,549 | $462K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.3% | 6,888 | 6,730 | $413K |
| G0008 | Administration of influenza virus vaccine | 6.1% | 12,224 | 12,165 | $399K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.0% | 5,189 | 5,162 | $324K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 3.9% | 2,329 | 1,703 | $257K |
| G0009 | Administration of pneumococcal vaccine | 2.1% | 4,295 | 4,280 | $139K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.1% | 1,144 | 1,119 | $72K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 531 | 531 | $61K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 2,457 | 2,439 | $44K |
89 more codes
| D1206 | Topical application of fluoride varnish | <1% | 2,757 | $34K |
| 99188 | <1% | 918 | $22K | |
| 96127 | <1% | 2,921 | $19K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,471 | $12K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 764 | $10K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 765 | $10K |
| 90651 | <1% | 3,100 | $9K | |
| 0124A | <1% | 395 | $9K | |
| 0001A | <1% | 223 | $9K | |
| 90686 | <1% | 12,155 | $8K | |
| 0002A | <1% | 177 | $7K | |
| 0072A | <1% | 431 | $6K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 60 | $6K |
| Q3014 | Telehealth originating site facility fee | <1% | 362 | $6K |
| 83655 | <1% | 1,745 | $6K | |
| 0154A | <1% | 245 | $5K | |
| 0054A | <1% | 174 | $5K | |
| 0071A | <1% | 457 | $4K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 33 | $4K |
| 90473 | <1% | 95 | $4K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 33 | $4K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 163 | $3K |
| 0081A | <1% | 229 | $3K | |
| 90670 | <1% | 4,887 | $3K | |
| 90734 | <1% | 2,039 | $3K | |
| 0082A | <1% | 174 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 46 | $2K |
| 0052A | <1% | 42 | $2K | |
| G0010 | Administration of hepatitis b vaccine | <1% | 41 | $1K |
| 87070 | <1% | 1,621 | $993.66 | |
| 99383 | <1% | 12 | $982.80 | |
| 90681 | <1% | 2,618 | $869.20 | |
| 90716 | <1% | 1,734 | $816.70 | |
| 85018 | <1% | 1,419 | $795.50 | |
| 0074A | <1% | 127 | $792.90 | |
| 99381 | <1% | 12 | $744.72 | |
| 0083A | <1% | 56 | $675.30 | |
| 90480 | <1% | 350 | $671.27 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,867 | $632.34 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 347 | $496.05 |
| 0051A | <1% | 12 | $443.76 | |
| 0173A | <1% | 27 | $430.84 | |
| 80061 | Lipid panel | <1% | 29 | $374.92 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 59 | $319.44 |
| 81002 | <1% | 1,087 | $248.90 | |
| 90723 | <1% | 1,576 | $244.95 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 503 | $222.49 |
| 17110 | <1% | 12 | $155.23 | |
| 0004A | <1% | 85 | $142.20 | |
| 90619 | <1% | 703 | $130.00 | |
| 83718 | <1% | 27 | $122.85 | |
| 82465 | <1% | 28 | $121.80 | |
| 87481 | <1% | 24 | $106.48 | |
| 81025 | <1% | 95 | $71.17 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 63 | $55.37 |
| 87511 | <1% | 12 | $53.24 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 12 | $49.76 |
| 90744 | <1% | 468 | $47.00 | |
| 87186 | <1% | 27 | $35.14 | |
| 90672 | <1% | 217 | $25.00 | |
| 87077 | <1% | 27 | $21.36 | |
| 36416 | 0% | 2,033 | $0.00 | |
| 90698 | 0% | 2,038 | $0.00 | |
| 90474 | 0% | 2,664 | $0.00 | |
| 90696 | 0% | 1,608 | $0.00 | |
| 91315 | 0% | 199 | $0.00 | |
| 91307 | 0% | 1,040 | $0.00 | |
| 90697 | 0% | 885 | $0.00 | |
| 91305 | 0% | 286 | $0.00 | |
| 91317 | 0% | 152 | $0.00 | |
| 91319 | 0% | 106 | $0.00 | |
| 91318 | 0% | 68 | $0.00 | |
| 90677 | 0% | 55 | $0.00 | |
| 90707 | 0% | 1,671 | $0.00 | |
| 90648 | 0% | 2,699 | $0.00 | |
| 90715 | 0% | 1,830 | $0.00 | |
| 90633 | 0% | 3,646 | $0.00 | |
| 91312 | 0% | 396 | $0.00 | |
| 90710 | 0% | 1,681 | $0.00 | |
| 90700 | 0% | 1,443 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 10,298 | $0.00 |
| 91300 | 0% | 510 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 26 | $0.00 |
| 91320 | 0% | 105 | $0.00 | |
| 91322 | 0% | 28 | $0.00 | |
| 90671 | 0% | 757 | $0.00 | |
| 90685 | 0% | 66 | $0.00 | |
| 91308 | 0% | 482 | $0.00 | |
| 91321 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Mainehealth | Portland, ME | $142.72M |
| Mainehealth | Portland, ME | $115.05M |
| Mainehealth | Biddeford, ME | $70.83M |
| Mainehealth | Brunswick, ME | $40.06M |
| Mainehealth | Farmington, ME | $22.62M |
| Mainehealth | Biddeford, ME | $10.89M |
| Mainehealth | Portland, ME | $5.46M |
| Mainehealth | Scarborough, ME | $5.04M |
| Mainehealth | Rockport, ME | $4.34M |
| Mainehealth | Scarborough, ME | $4.16M |
| Mainehealth | Portland, ME | $4.09M |
| Mainehealth | Scarborough, ME | $3.94M |
| Mainehealth | Portland, ME | $3.55M |
| Mainehealth | Waldoboro, ME | $3.43M |
| Mainehealth | Scarborough, ME | $3.18M |
| Mainehealth | Brunswick, ME | $2.77M |
| Mainehealth | Portland, ME | $2.68M |
| Mainehealth | Falmouth, ME | $2.10M |
| Mainehealth | Portland, ME | $1.87M |
| Mainehealth | Cape Elizabeth, ME | $1.82M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.